• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. AS LVP 20D 3SS CV; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. AS LVP 20D 3SS CV; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 2426-0007
Device Problems Free or Unrestricted Flow (2945); Infusion or Flow Problem (2964)
Patient Problem Overdose (1988)
Event Date 09/20/2020
Event Type  malfunction  
Manufacturer Narrative
Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident, and without this information, we are unable to determine where the device was manufactured.Therefore, bd corporate headquarters in (b)(4) has been listed, and the (b)(4) fda registration number has been used for the manufacture report number.Medical device expiration date: unknown.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Device manufacture date: unknown.(b)(4).
 
Event Description
It was reported that the unspecified bd¿ pri tubing had a check valve malfunction, and was too full resulting in overinfusion.The following information was provided by the initial reporter: material no: pri tubing; batch no: unknown.It was reported that the primary bag was found to be more full than the secondary resulting in an over infusion of vancomycin.Event description per email states, "from bd rep: since the programming data does not seem to conclusively show the rationale for the vancomycin being delivered faster than intended, that is making me think beyond the programming.With xxxx stating that the primary bag looked fuller at the end, it makes me suspicious in wondering if there was a faulty back check valve on the primary tubing that lead to the retrograde flow of the secondary infusion contents into the primary bag.This one way valve should have prevented that, but if there is a bit of glue residue that prevents it from sealing completely, it can cause retrograde flow.I suspect the tubing is gone!?! if not, sending this in for testing by customer advocacy could validate this suspicion.Since this can be isolated to one tubing vs.A lot, sending in another tubing from the same lot would not necessarily help in this situation.Has this been reported to customer advocacy yet for their tracking/trending of product complaints? i want to make sure they are aware of the potentially faulty back check valve for their awareness and monitoring.I have spoken with our new biomed.They feel this was a free flow incident related to the tubing.We don¿t have lot number for the tubing, but we still have the primary bag and secondary bag." on 25-sep-2020, "i do know that the primary bag was fuller after the event." "thanks for the collaboration on this incident¿.In looking at the data xxxxxxxxxx shared, i would agree¿.Vancomycin 1,000 mg/200 ml programmed at 200 ml/hr (or over 1 hr); started at 10:38 as a secondary; after a patient side occlusion alarm at the start of the infusion that was restarted quickly, it ran until 11:02 at 200 ml/hr.There were a series of door opened alarms, restart and stopping between 11:04-11:05.Since i do not believe the report is sharing provides a conclusive answer of why, i also try to think of other potentials for an over-infusion.Since this is a secondary delivery, i always consider the potential mechanics of an over-infusion.Was the secondary tubing connected properly into the upper y-site above the pump? did the primary bag look ¿fuller¿ or the secondary drip chamber dripping faster than expected, based on the potential that the back check/one way valve on the primary tubing was not working and there was retrograde flow of the secondary bag into the primary fluids." it looks like 1000mg was programmed at a rate of 200ml/h with a vtbi of 200ml to infuse over a duration of 3600 seconds(3600/60seconds=60 minutes).In roughly 23 minutes, 76 mls had infused.After a series of alarms an additional 3mls infused prior to being stopped.I see a programmed dose, but not a diluent.Usually it is 250 or 500mls plus generous overfill.Whole bag of vancomycin infused.On 9/20/20 in icu.
 
Manufacturer Narrative
The following fields have been updated with additional information: site legal name (fda): tijuana, mx.B.5.Describe event or problem: it was reported that as lvp 20d 3ss cv had a check valve malfunction and was too full resulting in over infusion.The following information was provided by the initial reporter: material no: pri tubing batch no: unknown.It was reported that the primary bag was found to be more full than the secondary resulting in an over infusion of vancomycin.Event description per email states: from bd rep: since the programming data does not seem to conclusively show the rationale for the vancomycin being delivered faster than intended, that is making me think beyond the programming.With stating that the primary bag looked fuller at the end, it makes me suspicious in wondering if there was a faulty back check valve on the primary tubing that lead to the retrograde flow of the secondary infusion contents into the primary bag.This one way valve should have prevented that, but if there is a bit of glue residue that prevents it from sealing completely, it can cause retrograde flow.I suspect the tubing is gone.If not, sending this in for testing by customer advocacy could validate this suspicion.Since this can be isolated to one tubing vs.A lot, sending in another tubing from the same lot would not necessarily help in this situation.I have spoken with our new biomed.They feel this was a free flow incident related to the tubing.We don't have lot number for the tubing but we still have the primary bag and secondary bag.25-sep-2020: "i do know that the primary bag was fuller after the event." "thanks for the collaboration on this incident in looking at the data shared, i would agree.Vancomycin 1,000 mg/200 ml programmed at 200 ml/hr (or over 1 hr) started at 10:38 as a secondary.After a patient side occlusion alarm at the start of the infusion that was restarted quickly, it ran until 11:02 at 200 ml/hr.There were a series of door opened alarms, restart and stopping between 11:04-11:05.Since i do not believe the report is sharing provides a conclusive answer of why ¿ i also try to think of other potentials for an over-infusion.Since this is a secondary delivery ¿ i always consider the potential mechanics of an over-infusion.Was the secondary tubing connected properly into the upper y-site above the pump? did the primary bag look ¿fuller¿ or the secondary drip chamber dripping faster than expected ¿ based on the potential that the back check/one way valve on the primary tubing was not working and there was retrograde flow of the secondary bag into the primary fluids." it looks like 1000mg was programmed at a rate of 200ml/h with a vtbi of 200ml to infuse over a duration of 3600 seconds (3600 / 60 seconds = 60 minutes).In roughly 23 minutes, 76 mls had infused.After a series of alarms an additional 3mls infused prior to being stopped.I see a programmed dose, but not a diluent.Usually it is 250 or 500mls plus generous overfill.Whole bag of vancomycin infused.On (b)(6) 2020 in icu.D.1.Medical device brand name: as lvp 20d 3ss cv.D.2.Medical device catalog#: 2426-0007.D.3.Medical device manufacturer: sistemas medicos alaris, s.A.De c.V.D.4.Unique identifier (udi)#: (b)(4).D.10.Device available for eval? yes.D.10.Returned to manufacturer on: 2020-10-21.G.1.Manufacturing location: sistemas medicos alaris, s.A.De c.V.G.5.Pma/510(k)#: k944320.H.3.Device returned to manufacturer: yes.
 
Event Description
It was reported that as lvp 20d 3ss cv had a check valve malfunction and was too full resulting in over infusion.The following information was provided by the initial reporter: material no: pri tubing batch no: unknown.It was reported that the primary bag was found to be more full than the secondary resulting in an over infusion of vancomycin.Event description per email states: from bd rep: since the programming data does not seem to conclusively show the rationale for the vancomycin being delivered faster than intended, that is making me think beyond the programming.With stating that the primary bag looked fuller at the end, it makes me suspicious in wondering if there was a faulty back check valve on the primary tubing that lead to the retrograde flow of the secondary infusion contents into the primary bag.This one way valve should have prevented that, but if there is a bit of glue residue that prevents it from sealing completely, it can cause retrograde flow.I suspect the tubing is gone!?! if not, sending this in for testing by customer advocacy could validate this suspicion.Since this can be isolated to one tubing vs.A lot, sending in another tubing from the same lot would not necessarily help in this situation.I have spoken with our new biomed.They feel this was a free flow incident related to the tubing.We don't have lot number for the tubing but we still have the primary bag and secondary bag.25-sep-2020: "i do know that the primary bag was fuller after the event." "thanks for the collaboration on this incident in looking at the data shared, i would agree.Vancomycin 1,000 mg/200 ml programmed at 200 ml/hr (or over 1 hr) started at 10:38 as a secondary.After a patient side occlusion alarm at the start of the infusion that was restarted quickly, it ran until 11:02 at 200 ml/hr.There were a series of door opened alarms, restart and stopping between 11:04-11:05.Since i do not believe the report is sharing provides a conclusive answer of why ¿ i also try to think of other potentials for an over-infusion.Since this is a secondary delivery ¿ i always consider the potential mechanics of an over-infusion.Was the secondary tubing connected properly into the upper y-site above the pump? did the primary bag look ¿fuller¿ or the secondary drip chamber dripping faster than expected ¿ based on the potential that the back check / one way valve on the primary tubing was not working and there was retrograde flow of the secondary bag into the primary fluids." it looks like 1000mg was programmed at a rate of 200ml / h with a vtbi of 200ml to infuse over a duration of 3600 seconds (3600 / 60 seconds = 60 minutes).In roughly 23 minutes, 76 mls had infused.After a series of alarms an additional 3mls infused prior to being stopped.I see a programmed dose, but not a diluent.Usually it is 250 or 500mls plus generous overfill.Whole bag of vancomycin infused.On (b)(6) 2020 in icu.
 
Event Description
It was reported that as lvp 20d 3ss cv had a check valve malfunction and was too full resulting in overinfusion.The following information was provided by the initial reporter: material no: pri tubing batch no: unknown.It was reported that the primary bag was found to be more full than the secondary resulting in an over infusion of vancomycin.Event description per email states: from bd rep: since the programming data does not seem to conclusively show the rationale for the vancomycin being delivered faster than intended, that is making me think beyond the programming.With xxxx stating that the primary bag looked fuller at the end, it makes me suspicious in wondering if there was a faulty back check valve on the primary tubing that lead to the retrograde flow of the secondary infusion contents into the primary bag.This one way valve should have prevented that, but if there is a bit of glue residue that prevents it from sealing completely, it can cause retrograde flow.I suspect the tubing is gone!?! if not, sending this in for testing by customer advocacy could validate this suspicion.Since this can be isolated to one tubing vs.A lot, sending in another tubing from the same lot would not necessarily help in this situation.I have spoken with our new biomed.They feel this was a free flow incident related to the tubing.We don¿t have lot number for the tubing but we still have the primary bag and secondary bag.On 25-sep-2020: "i do know that the primary bag was fuller after the event." "thanks for the collaboration on this incident¿.In looking at the data xxxxxxxxxx shared, i would agree¿.Vancomycin 1,000 mg/200 ml programmed at 200 ml/hr (or over 1 hr) started at 10:38 as a secondary after a patient side occlusion alarm at the start of the infusion that was restarted quickly, it ran until 11:02 at 200 ml/hr.There were a series of door opened alarms, restart and stopping between 11:04-11:05.Since i do not believe the report xxxxxxx is sharing provides a conclusive answer of why ¿ i also try to think of other potentials for an over-infusion¿.Since this is a secondary delivery ¿ i always consider the potential mechanics of an over-infusion¿.Was the secondary tubing connected properly into the upper y-site above the pump? did the primary bag look ¿fuller¿ or the secondary drip chamber dripping faster than expected ¿ based on the potential that the back check/one way valve on the primary tubing was not working and there was retrograde flow of the secondary bag into the primary fluids." it looks like 1000mg was programmed at a rate of 200ml/h with a vtbi of 200ml to infuse over a duration of 3600 seconds(3600/60seconds=60 minutes).In roughly 23 minutes, 76 mls had infused.After a series of alarms an additional 3mls infused prior to being stopped.I see a programmed dose, but not a diluent.Usually it is 250 or 500mls plus generous overfill.Whole bag of vancomycin infused.On (b)(6) 2020 in icu.
 
Manufacturer Narrative
H.6.Investigation: 1 primary tubing and 1 secondary tubing was returned by the customer.It was reported that the primary bag was found to be more full than the secondary resulting in an over infusion of vancomycin.The samples were examined for defects and abnormalities.No defects or abnormalities were observed.Functional testing was performed by using a primary bag filled with clear saline which was then used to prime the set.The secondary set was connected to a bag filled with a blue dye/water mixture, and then connected to the primary set.The sets were set up in a secondary infusion configuration with the fluid level of the secondary bag at least 9.5 inches higher than the primary bag fluid level, and all of the clamps closed.The secondary set was primed with the secondary roller clamp fully opened.Fluid flow was controlled using the primary roller clamp.After a few minutes, the blue dye/water mixture fluid from the secondary bag was found to be flowing through the check valve into the primary bag, indicating the check valve was failing to prevent backflow.The customer complaint can be verified.The issue was found to be due to a faulty check valve in the returned primary administration set.A quality notification has been sent to the supplier, and the sample has been sent for further investigation.We will continue to track this issue and watch for any emerging trends.A device history record review could not be performed on model 2426-0007 because a lot number was not provided by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS LVP 20D 3SS CV
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana NJ 22244
MX  22244
MDR Report Key10710059
MDR Text Key212310044
Report Number2243072-2020-01691
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup,Followup
Report Date 01/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2426-0007
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/21/2020
Date Manufacturer Received01/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-